iShares Biotechnology ETF (NASDAQ:IBB) Position Lowered by Savant Capital LLC

Savant Capital LLC lessened its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 6.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,374 shares of the financial services provider’s stock after selling 175 shares during the period. Savant Capital LLC’s holdings in iShares Biotechnology ETF were worth $314,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in IBB. Angeles Wealth Management LLC boosted its stake in shares of iShares Biotechnology ETF by 2,083.3% during the 4th quarter. Angeles Wealth Management LLC now owns 524 shares of the financial services provider’s stock valued at $69,000 after buying an additional 500 shares during the period. Martin Capital Advisors LLP boosted its position in iShares Biotechnology ETF by 9.6% in the fourth quarter. Martin Capital Advisors LLP now owns 14,439 shares of the financial services provider’s stock valued at $1,909,000 after buying an additional 1,270 shares in the last quarter. Newbridge Financial Services Group Inc. acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $33,000. Kestra Private Wealth Services LLC lifted its holdings in iShares Biotechnology ETF by 25.3% in the fourth quarter. Kestra Private Wealth Services LLC now owns 6,365 shares of the financial services provider’s stock valued at $842,000 after buying an additional 1,284 shares during the period. Finally, Counterweight Ventures LLC increased its stake in iShares Biotechnology ETF by 1.6% in the fourth quarter. Counterweight Ventures LLC now owns 8,592 shares of the financial services provider’s stock valued at $1,136,000 after purchasing an additional 138 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $136.55 on Tuesday. The firm has a fifty day simple moving average of $135.62 and a 200 day simple moving average of $140.86. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.